Emily’s Hope and Cisco have raised more than $1 million as part of Great Strides – a Cystic Fibrosis Foundation (CFF) fundraiser – becoming its top-performing national corporate team for the event. The Great Strides walk event is CFF’s largest national fundraiser that seeks to raise awareness about cystic…
News
‘Five Feet Apart,’ Film About Teens with CF and Young Love, Teams Up with Fashion Retailer rue21
“Five Feet Apart,” an upcoming romantic movie about two teens with cystic fibrosis (CF) who fall in love while undergoing treatment, now has a marketing partner — rue21. The film is set to open at theaters around the U.S. on March 15, a press release states. An apparel and…
Tobramycin, an antibiotic commonly used against Pseudomonas aeruginosa bacteria, reduces the bacteria’s load of virulence factors that impair the function of the CFTR (cystic fibrosis transmembrane conductance regulator) protein, a new study shows. The study, “Tobramycin reduces key virulence determinants in the proteome of Pseudomonas aeruginosa outer membrane vesicles,” was published in the journal…
Income level is the greatest single determinant of well-being in people with cystic fibrosis in the United States, said experts at a recent CF conference. Social worker Kim Reno, a manager at the Cystic Fibrosis Foundation’s Compass patient assistance program, estimates that actual healthcare determines only 20% of any…
Frazier Healthcare Partners has launched a new biopharmaceutical company called Recida Therapeutics, which will develop new therapies for serious antibiotic-resistant infections, including Pseudomonas aeruginosa, the leading cause of lung infections in cystic fibrosis (CF) patients. RC-01 is Recida’s lead therapy candidate for multidrug-resistant Gram-negative bacteria, a group of…
Enrollment for a Phase 3 clinical trial testing AeroVanc in patients with cystic fibrosis with methicillin-resistant Staphylococcus aureus (MRSA) lung infections is expected to be completed in the third quarter of this year — between July and September. AeroVanc is an inhaled formulation of the antibiotic vancomycin hydrochloride being developed…
SQI Diagnostics announced two new research agreements with research hospital University Health Network (UHN), Toronto, Canada, to simplify the assessment of lungs for transplant. By creating and licensing multiplexed protein assays and point-of-care diagnostic strategies, they intend to improve the health of donor organs so they can be transplanted safely…
Somer Love is sitting at her favorite local hangout, the Landmark Grill in suburban Midvale, happily devouring her lunch. Looming on the horizon to the east are Utah’s majestic Wasatch Mountains, but at more than 10,000 feet above sea level, the range is strictly off-limits to Love — as is…
Cystic Fibrosis Canada — Calgary and Southern Alberta Chapter will hold the 30th Annual 65 Roses Ladies Golf Classic event on June 17 to raise funds and awareness for cystic fibrosis (CF). The automotive dealership Lexus of Calgary will present the event, to be held at the Earl Grey…
Patients with cystic fibrosis (CF) whose lungs have never been colonized by the Pseudomonas aeruginosa bacterium have a milder form of the disease, a retrospective study based on registry data suggests. The study, “Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French…
Your CF Community

Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.
Recent Posts
- Inhaled therapy ETD001 well tolerated in healthy volunteers December 15, 2025
- This winter solstice, I reflect on moving from darkness to light December 12, 2025
- Safety concerns halt BX004 phage therapy trial for CF infection December 9, 2025
- Trikafta cuts need long-term for other CF treatments in real world December 8, 2025
- We shouldn’t have to fight so hard for healthcare coverage December 8, 2025